BURZYNSKI RESEARCH INSTITUTE INC 8-K

What Happened
Burzynski Research Institute, Inc. (BZYR) filed an 8-K on May 12, 2026 disclosing it may be unable to timely file its Annual Report on Form 10-K for the fiscal year ended February 28, 2026 (due on or about May 29, 2026). The company says Stanislaw R. Burzynski, M.D., Ph.D.—the Company’s President, Chief Financial Officer, Chairman and majority stockholder—historically funded operations but has informed the company he lacks the resources to cover certain SEC reporting costs (preparation, filing and related professional fees).

Key Details

• Filing date: May 12, 2026; impacted report: Form 10-K for fiscal year ended Feb 28, 2026 (due ~May 29, 2026).
• Source of shortfall: Dr. Stanislaw R. Burzynski (President, CFO, Chairman, majority owner) notified the company he cannot fund the SEC Reporting Costs.
• Anticipated effect: Possible failure to file the FY2026 10-K and subsequent periodic reports under Sections 13(a) and/or 15(d) of the Exchange Act.
• Potential SEC/market actions noted: trading suspension under Section 12(k) and/or administrative proceedings under Section 12(j) to suspend or revoke the Company’s registration, which could severely limit or eliminate trading liquidity.

Why It Matters
If Burzynski Research Institute becomes delinquent in its Exchange Act filings, investors could face reduced transparency (no timely audited annual report) and greater trading risk, including possible trading suspensions or delisting-type actions that would make buying or selling the stock difficult. The company also warns these are forward-looking statements dependent on funding and future actions by the SEC.